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Abstract  
 
Objectives: The purpose of the present study was to evaluate the association between pre-eclampsia 
and blood groups in a group of pregnant women hospitalized in a University Hospital in Porto 
Alegre, Brazil -Hospital São Lucas (HSL)/PUCRS.  
Study design: Our sample consisted of 10.040 pregnant women admitted to the maternity 
department of HSL between 2005 and 2010. The patients were reviewed retrospectively for 
inclusion. Medical records of 414 women were diagnosed as preeclampsia/eclampsia and were 
identified 9611 women to the control group. The patients were divided into two groups: the group 
with preeclampsia/eclampsia and the control group, and their blood groups were considered. Data 
were analyzed using SPSS for Windows version 17.0. Categorical data were summarized by counts 
and percentages, with the statistical significance evaluated by the Chi-square test. The null 
hypothesis was rejected when p<0.05. 
Main outcome measures: Maternal parameters were compared between control group and pre-
eclampsia, respectively, Systolic Blood Pressure (117±19,98 vs. 165±19,99); Diastolic Blood 
Pressure (73±14,23 vs. 106±14,24) and maternal weight at booking (73± 33 vs. 83± 33). For all 
data: mean+SD; P<0.05. In relation to blood groups, firstly they were stratified by Rh and ABO 
phenotypes, separately. After that the groups were stand together  
Results: No differences in blood group distribution were observed between controls and pre-
eclampsia for any analysis. (p>0.05).  
Conclusions: When we adopted stricter criteria for pre-eclampsia and a large sample from the same 
region we noted that the results did not show any association between blood groups and the 
development of pre-eclampsia.  
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Introduction 
 The ABO and Rh-Blood Group System are genetically determined and remain the most 
important blood groups systems clinically [1, 2]. The presence of D antigen confers Rh positive 
(Rh+), and the absence, Rh negative (Rh-). Furthermore pre-eclampsia is a major contributor to 
maternal and perinatal morbidity and mortality worldwide [3, 4]. These conditions are related to a 
poor extravillious trophoblast invasion and inadequate remodeling of maternal spiral arteries [5]. 
The disease mechanisms are thought to be multifactorial involving immunological, genetic factors, 
and may be related to blood clotting cascade [6-9], and associated with thrombosis of the placental 
vasculature and thrombophilia [10].  
 Despite several studies have examined the association between ABO /Rh systems and pre-
eclampsia no consensus exists in relation to the true association between pre-eclampsia and blood 
groups or to which specific blood group pre-eclampsia is related to, and what the magnitude of the 
association [11]. Dienst et al., was the first to suggest that isoimmunization to the A or B antigen 
was a cause of pre-eclampsia [12]. This finding was supported by Pike and Dickins who reported a 
significant excess of group O in pre-eclamptic women [13] which was not found by Clark et al., 
[14]. Also, ABO blood group has been associated with several thrombotic disease states; for 
instance, blood group non-O increased risk for venous thrombosis [15, 16] and ABO locus O¹ allele 
reduced risk for myocardial infarction [17]. Two systematic reviews and meta-analysis of studies 
analysing ABO blood group system in patients with pre-eclampsia was performed in 2008 and 
2013. In the first one no significant association was found [11] however in the later review, the 
analyses revealed an association between AB blood group and pre-eclampsia [18], as reported in a 
large study in 2012 [19]. Also, many authors reported these associations over the last century; 
eventually they were related only to one allele, or even only to Rhesus group [1,20-24]. 
Nevertheless, the association is not seen in all studies and there are very few large population-based 
studies [25,26]. Finally to the best of our knowledge there are not studies presenting how pre-
eclampsia and ABO/Rh systems are related in a Brazilian population. Thus the purpose of the 
present study was to evaluate this association in a group of pregnant women hospitalized University 
Hospital in Porto Alegre, Brazil -Hospital São Lucas (HSL)/PUCRS. 
 
Methods 
 Pre-eclampsia was defined as high blood pressure (≥ 140/90 mmHg) accompanied by 
proteinuria ≥ 300 mg/24h urine, after the twentieth week of pregnancy, and Eclampsia as the 
presence of seizures, coma or both not related to other changes in the central nervous system during 
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pregnancy or postpartum in women with pre-eclampsia [27]. Maternal blood group was coded as A, 
B, O, AB and Rh (+/-). Our sample consisted of 10.040 pregnant women admitted to the maternity 
department of São Lucas Hospital between 2005 and 2010. The patients were reviewed 
retrospectively for inclusion. Medical records of 414 women were diagnosed as 
preeclampsia/eclampsia and were identified 9611 women to the control group. The patients were 
divided into two groups: the group with preeclampsia/eclâmpsia and the control group and their 
blood groups were considered. Data were analyzed using SPSS for Windows version 17.0. 
Continuous variables are presented as mean ± standard deviation (SD) and tested by Student’s t test. 
Categorical data were summarized by counts and percentages, with the statistical significance 
evaluated by the Chi-square test. The null hypothesis was rejected when P<0.05. 
  
Results 
 Maternal parameters were compared between control group and pre-eclampsia, respectively, 
Systolic Blood Pressure (117 ± 19,98 vs. 165 ± 19,99); Diastolic Blood Pressure (73 ± 14,23 vs. 106 
± 14,24); Weight at the end of pregnancy (73,4 ± 33,03 vs. 83,11 ± 33,08). For all data: mean+SD; 
p<0.05. In relation to blood groups, firstly we stratified by Rh (Figure Aa) and ABO (Figure Ab) 
phenotypes. After that we stand together both blood systems (Figure B). No differences in blood 
group distribution were observed between controls and pre-eclampsia (p > 0.05).  
 
Discussion 
 The current study tried to refute reported correlation between blood groups and pre-
eclampsia/eclampsia using a large cohort in a Southern Brazilian population. Previous studies that 
report a positive relationship between blood groups and pre-eclampsia were conducted in different 
countries which have different characteristics of the blood phenotypes and used different criteria do 
characterize pre-eclampsia. Thus this association might be investigated with conflicting results [11, 
18]. For example, in Iraq, there was a significant decrease in group O type in patients with pre-
eclampsia compared to healthy controls [22] and in Colombia patients with Rh(-) were eleven times 
more likely to develop pre-eclampsia compared with the Rh(+) factor [23]. Spinillo et al., in 1995, 
in Italy and Hiltunen et al., in 2009, in Finland indentified blood group AB as a risk factor for 
severe pre-eclampsia [24,28]. Also, Sezik et al., in 2002, in Turkey, showed that almost half of the 
patients with the blood group O Rh(-) had HELLP syndrome in a severe pre-eclampsia population 
[1]. 
 In discussing some of the biometric problems involved in establishing associations between 
blood groups and diseases, Dr J.A. Fraser Roberts, in 1955 stresses the large number of cases 
 
5 
required and the importance of adopting rigid and precisely defined criteria [29]. Early studies in 
the fifties, who tried to demonstrate such a comparison, did not use the criterion of pre-eclampsia 
but considered pregnancy toxaemic or non-toxaemic, and the diagnosis of toxaemia was made by 
the presence of the least two of the following after 28th week of pregnancy: blood pressure ≥140/90 
mmHg; clinical oedema; albuminuria not due to infection. 
 Then, when we adopt stricter criteria for pre-eclampsia and a large sample from the same 
region we note that the results showed no relationship between blood groups and the development 
of pre-eclampsia. Probably the association found in others studies may be related to another risk 
factor involved in physiopathology of the disease as obesity, cardiovascular, hypertensive disorders 
and/or also vascular injuries. 
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